Balin BJ, Hudson AP. Etiology and pathogenesis of late-onset Alzheimer’s disease. Curr Allergy Asthma Rep. 2014;14:1–10.

Article  Google Scholar 

Mucke L. Alzheimer’s disease. Nature. 2009;461(7266):895–7.

Article  CAS  PubMed  Google Scholar 

Vilatela MEA, López-López M, Yescas-Gómez P. Genetics of Alzheimer’s disease. Arch Med Res. 2012;43(8):622–31.

Article  Google Scholar 

St George-Hyslop PH, Petit A. Molecular biology and genetics of Alzheimer’s disease. C R Biol. 2005;328(2):119–30.

Article  CAS  PubMed  Google Scholar 

Aydin D, Weyer SW, Müller UC. Functions of the APP gene family in the nervous system: insights from mouse models. Exp Brain Res. 2012;217:423–34.

Article  CAS  PubMed  Google Scholar 

Eikelenboom P, Veerhuis R, Van Exel E, Hoozemans JJM, Rozemuller AJM, van Gool WA. The early involvement of the innate immunity in the pathogenesis of lateonset Alzheimer’s disease: neuropathological, epidemiological and genetic evidence. Curr Alzheimer Res. 2011;8(2):142–50.

Article  CAS  PubMed  Google Scholar 

Bettcher BM, Tansey MG, Dorothée G, Heneka MT. Peripheral and central immune system crosstalk in Alzheimer disease—a research prospectus. Nat Rev Neurol. 2021;17(11):689–701.

Article  PubMed  PubMed Central  Google Scholar 

Abbott A. Depression: the radical theory linking it to inflammation. Nature. 2018;557(7706):633–5.

Article  CAS  Google Scholar 

Felger JC, Lotrich FE. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience. 2013;246:199–229.

Article  CAS  PubMed  Google Scholar 

Gałecki P, Talarowska M. Inflammatory theory of depression. Psychiatr Pol. 2018;52(3):437–47.

Article  PubMed  Google Scholar 

Dey A, HankeyGiblin PA. Insights into macrophage heterogeneity and cytokine-induced neuroinflammation in major depressive disorder. Pharmaceuticals. 2018;11(3):64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee C-H, Giuliani F. The role of inflammation in depression and fatigue. Front Immunol. 2019;10:1696.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abbott A. The brain inflamed. Nature. 2018;556(7702):426–8.

Article  CAS  PubMed  Google Scholar 

Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat Genet. 2019;51(3):404–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kao C-F, Jia P, Zhao Z, Kuo P-H. Enriched pathways for major depressive disorder identified from a genome-wide association study. Int J Neuropsychopharmacol. 2012;15(10):1401–11.

Article  CAS  PubMed  Google Scholar 

Kanhere A, Hertweck A, Bhatia U, Gokmen MR, Perucha E, Jackson I, et al. T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elements. Nat Commun. 2012;3:1268.

Article  PubMed  Google Scholar 

Harigai M, Kawamoto M, Hara M, Kubota T, Kamatani N, Miyasaka N. Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B. J Immunol. 2008;181(3):2211–9.

Article  CAS  PubMed  Google Scholar 

Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000;100(6):655–69.

Article  CAS  PubMed  Google Scholar 

Oestreich KJ, Weinmann AS. T-bet employs diverse regulatory mechanisms to repress transcription. Trends Immunol. 2012;33(2):78–83.

Article  CAS  PubMed  Google Scholar 

Fyall KM, Fong AM, Rao SB, Ibrahim JG, Waxweiler WT, Thomas NE. The TBX21 transcription factor T-1993C polymorphism is associated with decreased IFN-gamma and IL-4 production by primary human lymphocytes. Hum Immunol. 2012;73(6):673–6.

Article  CAS  PubMed Central  Google Scholar 

Wong M, Dong C, Maestre-Mesa J, Licinio J. Polymorphisms in inflammation related genes are associated with susceptibility to major depression and antidepressant response. Mol Psychiatry. 2008;13(8):800–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heidari F, Ansstas G, Ajamian F. CD33 mRNA has elevated expression levels in the leukocytes of peripheral blood in patients with late-onset Alzheimer’s disease. Gerontology. 2022;68(4):421–30.

Article  CAS  PubMed  Google Scholar 

Shibata N, Ohnuma T, Baba H, Arai H. Genetic association analysis between TDP-43 polymorphisms and Alzheimer’s disease in a Japanese population. Dement Geriatr Cogn Disord. 2009;28(4):325–9.

Article  CAS  PubMed  Google Scholar 

Jiang T, Yu J-T, Hu N, Tan M-S, Zhu X-C, Tan L. CD33 in Alzheimer’s disease. Mol Neurobiol. 2014;49:529–35.

Article  CAS  PubMed  Google Scholar 

You Y, Zhao W, Chen S, Tan W, Dan Y, Hao F, et al. Association of TBX21 gene haplotypes in a Chinese population with systemic lupus erythematosus. Scand J Rheumatol. 2010;39(3):254–8.

Article  CAS  PubMed  Google Scholar 

Parnell GP, Gatt PN, Krupa M, Nickles D, McKay FC, Schibeci SD, et al. The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease. Clin Immunol. 2014;151(1):16–24.

Article  CAS  PubMed  Google Scholar 

Mack M. Inflammation and fibrosis. Matrix Biol. 2018;68–69:106–21.

Article  PubMed  Google Scholar 

Gourh P, Agarwal SK, Divecha D, Assassi S, Paz G, Arora-Singh RK, et al. Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines. Arthritis Rheum. 2009;60(12):3794–806.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsuno N, Homma A. What is the association between depression and Alzheimer’s disease? Expert Rev Neurother. 2009;9(11):1667–76.

Article  PubMed  Google Scholar 

Organization WH. Depression and other common mental disorders: global health estimates. World Health Organization; 2017. WHO/MSD/MER/2017.2.

Lyketsos CG, Tune LE, Pearlson G, Steele C. Major depression in Alzheimer’s disease: an interaction between gender and family history. Psychosomatics. 1996;37(4):380–4.

Article  CAS  PubMed  Google Scholar 

Cantón-Habas V, Rich-Ruiz M, Romero-Saldaña M, Carrera-González MDP. Depression as a risk factor for dementia and Alzheimer’s disease. Biomedicines. 2020;8(11):457.

Article  PubMed  PubMed Central  Google Scholar 

Kuo C-Y, Stachiv I, Nikolai T. Association of late life depression,(non-) modifiable risk and protective factors with dementia and Alzheimer’s disease: literature review on current evidences, preventive interventions and possible future trends in prevention and treatment of dementia. Int J Environ Res Public Health. 2020;17(20):7475.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gatz JL, Tyas SL, St. John P, Montgomery P. Do depressive symptoms predict Alzheimer’s disease and dementia? J Gerontol A Biol Sci Med Sci. 2005;60(6):744–7.

Article  PubMed  Google Scholar 

Tapiainen V, Hartikainen S, Taipale H, Tiihonen J, Tolppanen A-M. Hospital-treated mental and behavioral disorders and risk of Alzheimer’s disease: a nationwide nested case-control study. Eur Psychiatry. 2017;43:92–8.

Article  CAS  PubMed  Google Scholar 

Hudon C, Escudier F, De Roy J, Croteau J, Cross N, Dang-Vu TT, et al. Behavioral and psychological symptoms that predict cognitive decline or impairment in cognitively normal middle-aged or older adults: a meta-analysis. Neuropsychol Rev. 2020;30:558–79.

Article  PubMed  Google Scholar 

Kuring J, Mathias J, Ward L. Risk of dementia in persons who have previously experienced clinically-significant depression, anxiety, or PTSD: a systematic review and meta-analysis. J Affect Disord. 2020;274:247–61.

Article  CAS  PubMed  Google Scholar 

Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF. Late-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013;202(5):329–35.

Article  PubMed